dPDL1-4

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NamedPDL1-4
Drug Alias NameN/A
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionProgrammed death-ligand 1 degradersHeat shock protein HSP90 modulators
TargetsProgrammed death-ligand 1Heat shock protein HSP90
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Medical University
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Medical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A